꽃가루 알레르기 시장 보고서 : 동향, 예측 및 경쟁 분석(-2030년)

Pollen Allergy Trends and Forecast

The future of the global pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets. The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are growing occurrence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.

• Lucintel forecasts that corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availability.
• Within this market, inhaled will remain the largest segment due to high growth of respiratory allergies.
• APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.

Emerging Trends in the Pollen Allergy Market

A few of the important trends observed in the pollen allergy market are driven by changes in demography and technological advancement-including environmental awareness.

• Personalized Allergy Treatments: Increasingly, there is focus on personalized medicine in the treatment of allergic conditions based on the specific characteristics of each individual's genetic makeup and natural environmental exposure. This is improving treatment outcomes and the quality of patients' lives.
• Digital Health Integration: The rise of digital health tools, including mobile apps and wearable devices, is enhancing pollen allergy management. These technologies help track symptoms, manage medications, and provide real-time pollen forecasts.
• Greater Use of Biologics: There is greater use of drugs in this class, as they act on specific pathways in the allergic response. This allows for better and more selective approaches to the treatment of individuals with severe allergies.
• Awareness of the Impact of the Environment: There is increased awareness regarding the current changes in the environment and their consequences for the levels of exposure to pollen, encouraging strategies for reducing the level of exposure and managing the symptoms of allergic reactions.
• Expanding the Basket of Immunotherapy Options: Besides sublingual and allergen immunotherapies, a widening array of immunotherapies is now available for allergy sufferers, affording more viable long-term treatment options and thus yielding better patient outcomes that give more momentum to the growth of the market.

These changes are reconditioning the pollen allergy market with more personalized, effective, and accessible treatment options. They are increasing awareness and improvements in management strategies to achieve better patient outcomes.

Recent Developments in the Pollen Allergy Market

The recent developments in pollen allergy markets reflect the growing trend toward effective treatment, treatment personalization, better diagnostic tools, and heightened mass awareness in order to improve patient care and tackle the growing prevalence of pollen allergy worldwide.

• Advancement in Immunotherapy: Improvement in sublingual and allergen-specific immunotherapies is offering superior long-term treatment options. These technological innovations are leading to increased compliance and reducing the intensity of allergy symptoms.
• Increased Adoption of Digital Health Tools: New mobile applications and wearable devices have allowed tracking of pollen levels along with the management of symptoms. These digital tools provide current data and personalized suggestions.
• Development of Biologic Drugs: New biologic treatments targeting specific pathways in allergic reactions are offering advanced options for patients with severe allergies. These drugs are leading to better and improved ways of treatment.
• Increased Research on Environmental Factors: Research on climate change and environmental pollution effects on pollen amounts is leading to better allergy management approaches. It is also influencing public health policies and modes of treatment.
• Increased Allergy Testing: Advanced diagnostics and availability of testing for allergies spur development through early detection and personalized treatment plans, better allergy management, and alleviating the sufferings of allergic people.

These are indeed changes in the face of the pollen allergy market, where overall improvement in the quality and effectiveness of the treatment options compensates for the growing need for personalized and effective allergy management.

Strategic Growth Opportunities for Pollen Allergy Market

The market for pollen allergies has provided ample opportunities for growth from a strategic standpoint, as this can be reflected in the following areas: application-driven, technological developments, an increase in awareness toward the disease, and associated needs or demand for overall management solutions of the allergic condition.

• Expanding Immunotherapy Services: Developing and expanding immunotherapy services, including sublingual services and allergen-specific therapies, increases significant growth potential. Advanced treatments, which are being increasingly patronized by patients due to their long-term effectiveness and other associated benefits, include:.
• Digital Health Solution Integration: Investment in digital health solutions, such as mobile apps, wearable devices that are minimally invasive for monitoring allergen exposure, and remote monitoring of the patients' body parameters-huge potential to enhance engagement of patients in their health and pollen allergy management, in real-time data, and treatment planning on a personal basis.
• Growth in Biologic Treatments: Growth in the development and commercialization of biologic drugs for severe allergies is at a critical opportunity. These treatments are targeted and are sought after increasingly due to their efficiency.
• Awareness Campaigns: By launching the sensitization educational campaigns on pollen allergy and treatments available, demand will be created and thereby drive the market for the company. Increased public awareness will result in the adoption of high rates of solutions for the management of allergies.
• Emerging Market Penetration: Emerging markets like India and China, depicting a high rise in prevalence due to allergies, will provide a huge growth potential. Molding products and services in line with the requirements of the emerging markets will capture a large and growing customer base.

The strategic opportunities for growth in the pollen allergy market brought innovation, expansion to the treatments, and improved patient care. Companies able to capitalize on opportunities are well diluted to navigate the market as it continues to transform.

Pollen Allergy Market Driver and Challenges

The pollen allergy market is driven as well as challenged by technological developments, economic factors, and regulatory concerns. Proper insight into the factors will help one wade through the market effectively.

The factors responsible for driving the pollen allergy market include:

1. Technological Developments: New diagnosis and treatment methods such as biologics and digital health solutions are driving growth in the market. This sets a better approach to dealing with pollen allergies and treated ways.

2. Increased Incidence of Allergies: Due to global increase in pollen allergies, the demand for better treatment and management is likely to rise, which in turn shall increase the market size and investment in allergy research.

3. Government Initiatives: Support for research in the domain of allergies through subsidies by the government and public health campaigns help to establish market growth. The policies to improve allergy management and solutions in treatment influence market dynamics.

4. Increasing Public Awareness: Increasing awareness on pollen allergy and its various methods of treatment is aiding in the acceptance of solutions for the management of allergies. Public education has made increasing public awareness possible.

5. Market Penetration due to Expansion of Healthcare Access: In line with the health needs, access and expansion into healthcare services and treatment or management of allergies, particularly in the fast-growing or emerging markets, are poised as strong drivers of the market. This, in turn, is making available efficient solutions for allergy management.

Challenges in the pollen allergy market are:

1. High Treatment Costs: The cost of highly developed allergy treatment, like biologics and immunotherapy, is unaffordable to some patients. This acts as a challenge to the growth and adoption in the market, especially in lower-income regions.

2. Regulatory Hurdles: New drugs and technology face strict regulatory requirements, which delay entry into the market and translate into growing development costs. Following such regulations is one of the key challenges the companies working in the allergy market face.

3. Variability of Allergic Reactions: It is the sophistication of the individual allergic reaction that has made the search for a common approach difficult. In this regard, variability influences how treatments can be effective; thus, it affects the growth of the market.

These drivers and challenges are pertinent forces changing the pollen allergy market, which not only determines new treatment developments but also the market dynamics and accessibility of care to patients. Working on these elements will be a key factor in the emergence of enterprises in the changing market scenario.

List of Pollen Allergy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies pollen allergy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pollen allergy companies profiled in this report include-

• ALK-Abello
• Circassia
• DBV Technologies
• Genentech
• GlaxoSmithKline
• HAL Allergy
• Johnson & Johnson
• Meda AB
• Merck & Co
• Mylan

Pollen Allergy by Segment

The study includes a forecast for the global pollen allergy by therapeutics drug class, product type, allergen type, end use, and region.

Pollen Allergy Market by Therapeutics Drug Class [Analysis by Value from 2018 to 2030]:

• Antihistamines
• Decongestants
• Corticosteroids
• Mast Cell Stabilizers
• Leukotriene Inhibitors
• Nasal Anticholinergics
• Immunomodulators
• Auto injectable Epinephrine
• Immunotherapy

Pollen Allergy Market by Product Type [Analysis by Value from 2018 to 2030]:

• Instruments
• Consumables
• Services

Pollen Allergy Market by Allergen Type [Analysis by Value from 2018 to 2030]:

• Food
• Inhaled
• Drug
• Others

Pollen Allergy Market by End Use [Analysis by Value from 2018 to 2030]:

• Diagnostic Laboratories
• Hospitals
• Others

Pollen Allergy Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Pollen Allergy Market

The pollen allergy market is evolving rapidly due to advancements in treatments, changing environmental conditions, and increased awareness of allergic reactions. These developments reflect a broader trend toward personalized and effective management of pollen allergies across different regions.

• United States: Over the past few years, new treatments for allergies, such as SLIT and new biologic medications, have grown in the U.S., which has helped the management of pollen allergy. More awareness among the general public and new digital health tools also help in the management of the allergy.
• China: In China, there is growing infiltration by advanced allergy testing and immunotherapy options. Increasing prevalence, government interest in allergy research and treatment, along with high pollen counts in urban areas because of climate change, is driving market growth in the country.
• Germany is no doubt at the front line in advancing the development and application of precision medicine in managing allergies through personalized immunotherapy and improved diagnostic tools. It also dedicates some seriousness to the environmental policies it creates with a view to reduced pollen exposure and improving allergy management at large.
• India: With availability, the awareness about allergy treatments is increasing. Greater pollen allergies and availability of treatments at reasonable prices are the reasons for the market's growth. Besides, the country is putting emphasis on diagnostic capability building and health education of the general public.
• Japan: Japanese markets are increasingly focusing on more sophisticated allergen-specific immunotherapy and nasal sprays. In recent times, they have also integrated digital health technologies that help track symptoms and manage them. With increased research and development, the treatments are going to be more specific in the case of pollen allergies.

Features of the Global Pollen Allergy Market

Market Size Estimates: Pollen allergy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pollen allergy market size by various segments, such as by therapeutics drug class, product type, allergen type, end use, and region in terms of value ($B).

Regional Analysis: Pollen allergy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapeutics drug classes, product types, allergen types, end uses, and regions for the pollen allergy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pollen allergy market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the pollen allergy market size?

Answer: The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030.

Q2. What is the growth forecast for pollen allergy market?

Answer: The global pollen allergy market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the pollen allergy market?

Answer: The major drivers for this market are growing occurrence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.

Q4. What are the major segments for pollen allergy market?

Answer: The future of the pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets.

Q5. Who are the key pollen allergy market companies?

Answer: Some of the key pollen allergy companies are as follows:

• ALK-Abello
• Circassia
• DBV Technologies
• Genentech
• GlaxoSmithKline
• HAL Allergy
• Johnson & Johnson
• Meda AB
• Merck & Co
• Mylan

Q6. Which pollen allergy market segment will be the largest in future?

Answer: Lucintel forecasts that corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availability.

Q7. In pollen allergy market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the pollen allergy market by therapeutics drug class (antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, immunomodulators, auto injectable epinephrine, and immunotherapy), product type (instruments, consumables, and services), allergen type (food, inhaled, drug, and others), end use (diagnostic laboratories, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Pollen Allergy Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Pollen Allergy Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Pollen Allergy Market by Therapeutics Drug Class
  • 3.3.1: Antihistamines
  • 3.3.2: Decongestants
  • 3.3.3: Corticosteroids
  • 3.3.4: Mast Cell Stabilizers
  • 3.3.5: Leukotriene Inhibitors
  • 3.3.6: Nasal Anticholinergics
  • 3.3.7: Immunomodulators
  • 3.3.8: Auto injectable Epinephrine
  • 3.3.9: Immunotherapy
• 3.4: Global Pollen Allergy Market by Product Type
  • 3.4.1: Instruments
  • 3.4.2: Consumables
  • 3.4.3: Services
• 3.5: Global Pollen Allergy Market by Allergen Type
  • 3.5.1: Food
  • 3.5.2: Inhaled
  • 3.5.3: Drug
  • 3.5.4: Others
• 3.6: Global Pollen Allergy Market by End Use
  • 3.6.1: Diagnostic Laboratories
  • 3.6.2: Hospitals
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Pollen Allergy Market by Region
• 4.2: North American Pollen Allergy Market
  • 4.2.1: North American Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
  • 4.2.2: North American Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
• 4.3: European Pollen Allergy Market
  • 4.3.1: European Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
  • 4.3.2: European Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
• 4.4: APAC Pollen Allergy Market
  • 4.4.1: APAC Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
  • 4.4.2: APAC Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
• 4.5: ROW Pollen Allergy Market
  • 4.5.1: ROW Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
  • 4.5.2: ROW Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Pollen Allergy Market by Therapeutics Drug Class
  • 6.1.2: Growth Opportunities for the Global Pollen Allergy Market by Product Type
  • 6.1.3: Growth Opportunities for the Global Pollen Allergy Market by Allergen Type
  • 6.1.4: Growth Opportunities for the Global Pollen Allergy Market by End Use
  • 6.1.5: Growth Opportunities for the Global Pollen Allergy Market by Region
• 6.2: Emerging Trends in the Global Pollen Allergy Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Pollen Allergy Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pollen Allergy Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: ALK-Abello
• 7.2: Circassia
• 7.3: DBV Technologies
• 7.4: Genentech
• 7.5: GlaxoSmithKline
• 7.6: HAL Allergy
• 7.7: Johnson & Johnson
• 7.8: Meda AB
• 7.9: Merck & Co
• 7.10: Mylan